Dear RWE Collaborative Members,
We are delighted to announce our upcoming RWE Collaborative SIG Meeting during the ISPE 2025 Annual Meeting:
📅 Sunday, August 24, 2025
🕖 7:00 PM – RWE Collaborative SIG Meeting
📍 Room 210 (Convention Center)
Following the meeting, please join us for an informal social gathering:
🍻 City Tap House – Penn Quarter
🕢 7:30 PM (after our meeting)
📍 901 9th St NW, Washington, DC 20001
This will be a great opportunity to connect with fellow members, celebrate our community's accomplishments, and network in a relaxed setting.
RWE Collaborative Member Presentations at ISPE 2025
We are also proud to highlight the exciting work of our members at ISPE 2025. A summary of presentations is attached to this email. Please take a moment to review and plan to attend sessions that align with your interests - and join us in supporting our colleagues!
Spotlight Poster Session - Tuesday, August 26, 12:15-1:15 PM ET, Hall D
|
Poster ID
|
Title
|
|
SLC-041
|
Remdesivir and Renal Outcomes in Hospitalized COVID-19 Patients Without Severe Renal Impairment: A Retrospective Cohort Study
|
|
SLC-042
|
Characterizing Neuropsychiatric Adverse Events of Semaglutide Reported in FAERS: Analysis of Off-Label and On-Label Use
|
|
SLC-043
|
Utilization of Real-World Evidence in Drug Approvals at the European Medicines Agency from 2020 to 2023
|
|
SLC-044
|
Validity of German ICD-10-GM Diagnosis Codes for Myocardial Infarction against Chart Review of Electronic Health Records
|
|
SLC-045
|
Mapping the Overall Safety Profile of Levothyroxine-Related Adverse Events: a Disproportionality Analysis on Individual Case Safety Reports Collected by the FAERS
|
|
SLC-046
|
Real-World Effectiveness of Osteoporosis Medications in Reducing Fracture Rates Among Men
|
|
SLC-047
|
EU-Wide Survey on Key Stakeholders' Knowledge, Opinions and Interests on Real-World Evidence in the Regulatory Process
|
|
SLC-048
|
Association between COVID-19 and thrombotic events: using Super Learner algorithm combined with doubly robust methods.
|
Symposium Presentations
|
Presentation Title
|
Author
|
Date & Time
|
Location
|
|
Navigating Around Quicksand: Mapping the Complexites of Externally Controlled Trial (ECT) Designs
|
Annie McNeill
|
Monday, Aug 25, 1-2:30pm
|
Room 208AB
|
|
Environmental Challenges to Supply Chain and Drug Shortages
|
Luciane Lopes
|
Tuesday, Aug 26, 10:30 AM - 12:00 PM ET
|
Room 206
|
|
The Future of Pharmacovigilance: Accelerating Signal Identification With Electronic Healthcare Data
|
Catherine Cohet
|
Sunday, Aug 24, 5:15–6:45PM EST
|
Room 202AB
|
|
What can pharmacoepidemiologists do to enhance vaccine confidence?
|
Catherine Cohet
|
Sunday, Aug 24, 1:30 PM - 3:00 PM ET
|
Room 206
|
Poster Presentations
Sunday, August 24, 2025
|
Presentation Title
|
Author
|
|
(A-219) Characterization of Healthcare Providers of a Cohort of Patients from Claims Data Based on Propagated Information from Linkage to Patient Encounters
|
Dana Teltsch
|
|
(SLA-065) Applications of Machine Learning in Epidemiologic Research Utilizing Administrative Claims and/or Structured Electronic Health Record Data
|
Dana Teltsch
|
|
Antidepressant Use among US Nursing Home Residents with ADRD in 2018
|
Shiwei liang
|
|
Costs and Lost Time for Employees whose Spouses have Dementia and/or Alzheimer's Disease and Patient Direct Costs
|
Richard Brook
|
|
Patients' and caregivers' understanding of the serious risks of opioid analgesics and how to use these products safely: A patient/caregiver survey
|
Anna Wentz
|
Monday, August 25, 2025
|
Presentation Title
|
Author
|
|
Pharmacoepidemiological study about the usage of antidepressants in young adults in Greece
|
Christos Kontogiorgis
|
|
Employee Care Partners of Spouses with Parkinson's Disease: Analysis of Patient and Care Partner (Direct Medical, Rx, and Total) Costs and Care Partner Lost Work Time
|
Richard Brook
|
|
Algorithmically Confirming Patients with Type 1 Diabetes Using Claims Data
|
Richard Brook
|
Tuesday, August 26, 2025
|
Presentation Title
|
Author
|
|
Risk of Atrial Fibrillation After Bivalent COVID-19 Vaccination During the 2022-2023 Season
|
Lina Sy
|
|
(C-131) Conformal Prediction Framework and Selective Classification for Establishing the Credibility of Machine Learning Models – Application in Claims Data
|
Dana Teltsch
|
|
Trends in Insulin Utilization and SARIMA Forecasting: A Time-Series Analysis in Greece (2016–2023) using IQVIA dataset
|
Christos Kontogiorgis
|
|
Clinical course and outcomes of myocarditis/pericarditis cases following mRNA-1273 vaccination compared to cases not following COVID-19 vaccination: interim analysis of a VAC4EU cohort study
|
Laura Zwiers
|
|
Risk factors for myocarditis/pericarditis following mRNA-1273 vaccination: interim analysis of a VAC4EU case-cohort study
|
Laura Zwiers
|
|
Does Health Plan Enrollment Data Support Long-term follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD)
|
Dan Beachler
|
|
Feasibility of Supplementing Single-Arm Trials with External Control Arms – Evaluation of German Real-World Data
|
Martin Russek
|
We look forward to seeing many of you at the meeting and social event, and to celebrating the strong contributions of the RWE Collaborative at ISPE 2025.
Warm regards,
On behalf of the RWE Collaborative Leadership Team
------------------------------
Tien Tran
University of Maryland School of Pharmacy
Baltimore MD
------------------------------